Next Article in Journal
Studies on Anticonvulsant Effects of Novel Histamine H3R Antagonists in Electrically and Chemically Induced Seizures in Rats
Next Article in Special Issue
PWCDA: Path Weighted Method for Predicting circRNA-Disease Associations
Previous Article in Journal
Anisotropic Gold Nanoparticles in Biomedical Applications
Previous Article in Special Issue
PR/SET Domain Family and Cancer: Novel Insights from The Cancer Genome Atlas
Review

Roles of Tristetraprolin in Tumorigenesis

Department of Biological Science, Dong-A University, Busan 49315, Korea
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2018, 19(11), 3384; https://doi.org/10.3390/ijms19113384
Received: 5 October 2018 / Revised: 25 October 2018 / Accepted: 26 October 2018 / Published: 29 October 2018
Genetic loss or mutations in tumor suppressor genes promote tumorigenesis. The prospective tumor suppressor tristetraprolin (TTP) has been shown to negatively regulate tumorigenesis through destabilizing the messenger RNAs of critical genes implicated in both tumor onset and tumor progression. Regulation of TTP has therefore emerged as an important issue in tumorigenesis. Similar to other tumor suppressors, TTP expression is frequently downregualted in various human cancers, and its low expression is correlated with poor prognosis. Additionally, disruption in the regulation of TTP by various mechanisms results in the inactivation of TTP protein or altered TTP expression. A recent study showing alleviation of Myc-driven lymphomagenesis by the forced expression of TTP has shed light on new therapeutic avenues for cancer prevention and treatment through the restoration of TTP expression. In this review, we summarize key oncogenes subjected to the TTP-mediated mRNA degradation, and discuss how dysregulation of TTP can contribute to tumorigenesis. In addition, the control mechanism underlying TTP expression at the posttranscriptional and posttranslational levels will be discussed. View Full-Text
Keywords: tristetraprolin (TTP); tumorigenesis; posttranscriptional regulation; adenosine and uridine-rich elements (AREs) tristetraprolin (TTP); tumorigenesis; posttranscriptional regulation; adenosine and uridine-rich elements (AREs)
Show Figures

Graphical abstract

MDPI and ACS Style

Park, J.-M.; Lee, T.-H.; Kang, T.-H. Roles of Tristetraprolin in Tumorigenesis. Int. J. Mol. Sci. 2018, 19, 3384. https://doi.org/10.3390/ijms19113384

AMA Style

Park J-M, Lee T-H, Kang T-H. Roles of Tristetraprolin in Tumorigenesis. International Journal of Molecular Sciences. 2018; 19(11):3384. https://doi.org/10.3390/ijms19113384

Chicago/Turabian Style

Park, Jeong-Min, Tae-Hee Lee, and Tae-Hong Kang. 2018. "Roles of Tristetraprolin in Tumorigenesis" International Journal of Molecular Sciences 19, no. 11: 3384. https://doi.org/10.3390/ijms19113384

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop